AVIR — ATEA PHARMACEUTICALS INC

Ownership history in Rangeley Capital, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Rangeley Capital, LLC reported a position in ATEA PHARMACEUTICALS INC (AVIR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.24% (2025 Q4)
Avg. % of fund
0.22%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 80,000 — 0% 0.24% $286K $3.57
2025 Q3 ADDED 80,000 +27,000 +50.9% 0.20% $232K $2.90
2025 Q2 INITIATED 53,000 — — 0.23% $191K $3.60
% of Fund (quarterly)    AVIR price (monthly, adj. close)

Other funds also holding AVIR

As of 2025 Q4 — sorted by position size

BML Capital Management, LLC 3Y 23.11% CM Management, LLC 3Y 1.07% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.85% Bain Capital Life Sciences Investors, LLC 3Y 7Y 0.68% Aldebaran Capital, LLC 3Y 0.29% Auour Investments LLC 0.2% NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.15% Opaleye Management Inc. 3Y 7Y 0.08% Sunpointe, LLC 0.01% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.01%
← Back to Rangeley Capital, LLC Holdings